Is Crinetics Pharmaceuticals, Inc. (CRNX) a Buy, Sell, or Hold?
NASDAQ : CRNX
Crinetics Pharmaceuticals, Inc.
$83.9 USD
$0.19 (0.23%)
- Volume
- 3.29M
- Average Volume
- 3.3M
- Market Capitalization
- $8.88B
- P/E Ratio
- -16.32
- Dividend Yield
- 0.00%
- Price Target
- $85.00
- Year High
- $84.00
- Year Low
- $25.83
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $18.60
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-1.3% DOWNSIDE
$85.00 Price Target
UPSIDE/DOWNSIDE HIGH
-1.3% DOWNSIDE
$85.00 Price Target High
UPSIDE/DOWNSIDE LOW
52.5% UPSIDE
$55.00 Price Target Low
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Stifel Nicolaus | Alex Thompson | $85 | $83.5 | 2026-07-08 09:15 AM | 1.8% |
| UBS | Ashwani Verma | $55 | $38.68 | 2026-07-02 04:38 AM | 42.2% |
| Stifel Nicolaus | Alex Thompson | $83 | $36.06 | 2026-06-22 09:34 AM | 130.2% |
| H.C. Wainwright | Douglas Tsao | $81 | $34.47 | 2026-06-15 06:48 AM | 135.0% |
| Evercore ISI | Gavin Clark-Gartner | $88 | $37.71 | 2026-05-15 08:22 AM | 133.4% |